Exciting news on the lupus research front. After a strong Phase 1, an experimental lupus therapy from Argos Therapeutics is showing promise.
Positive Phase 1 clinical trail results were released by Argos at the 2012 EULAR (European League Against Rheumatism) Congress in Berlin, earlier this month. Preliminary research was funded by the Alliance for Lupus Research. We are proud to have contributed to this research development.
Read the story to get details.
